Nadeem Riaz

Medicine · Health Sciences

70h-index28.0kcitations694works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(226), Cancer Genomics and Diagnostics(120), Salivary Gland Tumors Diagnosis and Treatment(102), Cancer Immunotherapy and Biomarkers(95), Head and Neck Surgical Oncology(74)

Publications691 total

Supplementary Figure 2 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Figure 3 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Supplementary Table 1 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Figure 4 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Data from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Supplementary Figure 1 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Figure 1 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Supplementary Figure 4 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Figure 2 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Table 1 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Supplementary Figure 5 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Supplementary Figure 3 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Supplementary Table 2 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Supplementary Figure 6 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High <i>CST2</i> Expression and a Favorable Prognosis
2026Open Access
Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer
Nature Genetics·2025· 1 citedOpen Access
Organ Preservation for Nasal Cavity Cancers Using Definitive Radiotherapy for Avoiding Rhinectomy
JAMA Oncology·2025Open Access
Optimal post-treatment surveillance strategy for human papillomavirus-positive oropharyngeal cancer
Cell Reports Medicine·2025Open Access
Osteoradionecrosis After Intensity-Modulated Radiation Therapy or Proton Therapy in Oropharyngeal Carcinoma
JAMA Otolaryngology–Head & Neck Surgery·2025· 1 citedOpen Access
Supplementary Figure S1 from Evolution and Co-occurrence of PI3K Pathway Gene Mutations in Endometrial Carcinoma Molecular Subtypes at the Single-Cell Level
2025Open Access
Supplementary Table S2 from Evolution and Co-occurrence of PI3K Pathway Gene Mutations in Endometrial Carcinoma Molecular Subtypes at the Single-Cell Level
2025Open Access
page 1 of 35Next →

Frequent Co-authors

Timothy A. Chan(26), Luc G.T. Morris(21), Nancy Y. Lee(17), Vladimir Makarov(16), Fengshen Kuo(13), Simon N. Powell(13), Jorge S. Reis‐Filho(12), A. Ari Hakimi(9), Richard J. Wong(9), Michael F. Berger(9), Ian Ganly(9), Robert Samstein(7), Ahmet Zehir(7), Alan L. Ho(7), Jonathan J. Havel(7), Alexis Desrichard(7), Diego Chowell(7), Vinod P. Balachandran(7), Sean M. McBride(7), Eric J. Sherman(7)